GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » 3SBio Inc (OTCPK:TRSBF) » Definitions » Operating Cash Flow per Share

3SBio (TRSBF) Operating Cash Flow per Share : $0.18 (TTM As of Dec. 2024)


View and export this data going back to 2018. Start your Free Trial

What is 3SBio Operating Cash Flow per Share?

3SBio's operating cash flow per share for the six months ended in Dec. 2024 was $0.12. 3SBio's operating cash flow per share for the trailing twelve months (TTM) ended in Dec. 2024 was $0.18.

During the past 12 months, the average Operating Cash Flow per Share Growth Rate of 3SBio was 48.60% per year. During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 25.70% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was 13.00% per year. During the past 10 years, the average Operating Cash Flow per Share Growth Rate was 16.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.

The historical rank and industry rank for 3SBio's Operating Cash Flow per Share or its related term are showing as below:

TRSBF' s 3-Year OCF Growth Rate Range Over the Past 10 Years
Min: 2.8   Med: 20.4   Max: 25.8
Current: 25.7

During the past 11 years, 3SBio's highest 3-Year average Operating Cash Flow per Share Growth Rate was 25.80% per year. The lowest was 2.80% per year. And the median was 20.40% per year.

TRSBF's 3-Year OCF Growth Rate is ranked better than
68.17% of 1219 companies
in the Biotechnology industry
Industry Median: 9.2 vs TRSBF: 25.70

3SBio Operating Cash Flow per Share Historical Data

The historical data trend for 3SBio's Operating Cash Flow per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

3SBio Operating Cash Flow per Share Chart

3SBio Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Operating Cash Flow per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.08 0.09 0.12 0.12 0.18

3SBio Semi-Annual Data
Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Operating Cash Flow per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.06 0.07 0.05 0.06 0.12

Competitive Comparison of 3SBio's Operating Cash Flow per Share

For the Biotechnology subindustry, 3SBio's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


3SBio's Price-to-Operating-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, 3SBio's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where 3SBio's Price-to-Operating-Cash-Flow falls into.


;
;

3SBio Operating Cash Flow per Share Calculation

Operating Cash Flow per Share is the amount of Cash Flow from Operations per outstanding share of the company's stock.

3SBio's Operating Cash Flow per Share for the fiscal year that ended in Dec. 2024 is calculated as

Operating Cash Flow per Share (A: Dec. 2024 )=Cash Flow from Operations (A: Dec. 2024 )/Shares Outstanding (Diluted Average) (A: Dec. 2024 )
=439.691/2466.608
=0.18

3SBio's Operating Cash Flow per Share for the quarter that ended in Dec. 2024 is calculated as

Operating Cash Flow per Share (Q: Dec. 2024 )=Cash Flow from Operations (Q: Dec. 2024 )/Shares Outstanding (Diluted Average) (Q: Dec. 2024 )
=289.608/2500.675
=0.12

Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was $0.18

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


3SBio Operating Cash Flow per Share Related Terms

Thank you for viewing the detailed overview of 3SBio's Operating Cash Flow per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


3SBio Business Description

Industry
Traded in Other Exchanges
Address
No. 3 A1, Road 10, Shenyang Economy and Technology Development Zone, Shenyang, CHN, 110027
3SBio Inc is a biotechnology company. As a pioneer in the Chinese biotechnology industry, the Group has extensive expertise in researching, developing, manufacturing, and marketing biopharmaceuticals. The core products of the Group include several biopharmaceutical drugs, TPIAO recombinant human erythropoietin rhEPO products EPIAO and SEPO, Yisaipu, Cipterbin, and a small molecule drug, Mandi. Except for minoxidil, an over-the-counter drug, the others are all older-generation biologics.

3SBio Headlines

No Headlines